Antibody-mediated status epilepticus: A retrospective multicenter survey

European Neurology

Volumn 68, Issue 5, 2012, Pages 310-317

  Holzer, Franz Josef ^a   Rossetti, Andrea O ^b   Heritier Barras, Anne Chantal ^a   Zumsteg, Dominik ^c   Roebling, Robert ^d   Huber, Roman ^d   Lerche, Holger ^d,e   Kiphuth, Ines C ^f   Bardutzky, Jürgen ^f   Bien, Christian G ^g   Tröger, Mathias ^h   Schoch, Gaby ^h   Prüss, Harald ⁱ   Seeck, Margitta ^a  

^a ElectroEncephaloGraphie et Eval Prechirurgicale de l'ePilepsie   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g UNIVERSITY OF BONN   (Germany)

^h Inselspital   (Switzerland)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antiepileptics; Autoimmune encephalitis; Immunomodulatory treatment; Patient outcome; Status epilepticus

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; CYCLOPHOSPHAMIDE; DIAZEPAM; ETIRACETAM; FELBAMATE; GABAPENTIN; HARKOSERIDE; IMMUNOGLOBULIN; KETAMINE; LAMOTRIGINE; LORAZEPAM; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; OLIGOCLONAL BAND; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; PROPOFOL; RECEPTOR ANTIBODY; STEROID; THIOPENTAL; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTICONVULSANT THERAPY; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; DISEASE DURATION; DRUG BLOOD LEVEL; EPILEPTIC STATE; FEMALE; HUMAN; IMMUNOMODULATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OUTCOME ASSESSMENT; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVIEW; SEX RATIO; STEROID THERAPY; VAGUS NERVE STIMULATION;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; SEIZURES; STATUS EPILEPTICUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867192164     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000341143     Document Type: Review

References (18)

1. Palace J, Lang B: Epilepsy: an autoimmune disease? J Neurol Neurosurg Psychiatry 2000; 69: 711-714.
2. McKnight K, Jiang Y, Hart Y, et al: Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005; 65:1730-1736.
3. Vincent A, Irani SR, Lang B: The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr Opin Neurol 2010; 23: 144-150.
4. Dalmau J: Status epilepticus due to paraneo-plastic and nonparaneoplastic encephaliti-des. Epilepsia 2009; 50(suppl 12):58-60.
5. Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, et al: Cellular and synaptic mechanisms of anti-NMDA receptor en-cepha litis. J Neurosci 2010; 30: 5866-5875.
6. Manto MU, Laute MA, Aguera M, Roge-mond V, Pandolfo M, Honnorat J: Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol 2007; 61:544-551.
7. Nociti V: Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosup-pressive treatment. Eur J Neurol 2010; 17:e5.
8. Kanter IC, Huttner HB, Staykov D, Biermann T, Struffert T, Kerling F, et al: Cyclo-phosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia 2008; 49:914-920.
9. Suleiman J, Brenner T, Gill D, Brilot F, Antony J, Vincent A, et al: VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology 2011; 76:1252-1255.
10. Grujic J, Bien CG, Pollo C, Rossetti AO: Vagus nerve stimulator treatment in adult-onset Rasmussen's encephalitis. Epilepsy Behav 2011; 20: 123-125.
11. Maeder-Ingvar M, Prior JO, Irani SR, Rey V, Vincent A, Rossetti AO: FDG-PET hyperac-tivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis. J Neurol Neurosurg Psychiatry 2011; 82: 235-6.
12. Voskuhl R: Sex differences in autoimmune diseases. Biol Sex Differ 2011; 2: 1.
13. Dalmau J: Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7:1091-8.
14. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011; 10:63-74.
15. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D: A prospective, population-based epidemiologic study of status ep-ilepticus in Richmond, Virginia. Neurology 1996; 46:1029-1035.
16. Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB: Prognosis of status epilepti-cus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neuro-surg Psychiatry 2006; 77:611-615.
17. Prüss H, Dalmau J, Harms L, Höltje M, Ah-nert-Hilger G, Borowski K, Stoecker W, Wandinger KP: Retrospective analysis of NMDA receptor antibodies in encephalitis of unk now n origin. Neurology 2010; 75: 1735-1739.
18. Davies G, Irani SR, Coltart C, Ingle G, Amin Y, Taylor C, Radcliffe J, Hirsch NP, Howard RS, Vincent A, Kullmann DM: Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med 2010; 38:679-682.